Loading...
BIOLASE, Inc.
BIOL•NASDAQ
HealthcareMedical - Devices
$0.02
$0.00(27.39%)
BIOLASE, Inc. (BIOL) AI-Powered Stock Analysis
See how BIOLASE, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerBIOLASE, Inc. (BIOL) Stock Overall Grade
BIOLASE, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to BIOLASE, Inc.'s overall stock rating.
Forecast
C+Score
52/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
B+Score
70/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
50/100Component Analysis Explained
Understand the key factors behind each BIOLASE, Inc. stock grade, including financials, comparisons, and forecasts.